Dr. Armen is Chairman and Chief Executive Officer of Agenus Inc., the biotechnology company he co-founded in 1994. From mid-2002 through 2004, he served as Chairman of the Board of Directors for the biopharmaceutical company Elan Corporation, plc which he successfully restructured. Dr. Armen serves as non-executive Chairman of the Board of Protagenic Therapeutics, a biotechnology company focusing on human brain hormones for the treatment of neurological and metabolic disorders. He also serves as Founder and Chairman of the Children of Armenia Fund (COAF), a philanthropic organization which he founded in 2000; COAF is dedicated to the development of children and youth in Rural Armenia.

Recent Posts

Forward Looking Statements

This website contains information regarding our future discovery and development efforts, our collaborations, our operating results and financial position, our business strategy, and other objectives for future operations. This information constitutes a forward-looking statement within the meaning of the Private Securities Litigation Reform Act of 1995. There are a number of risks and uncertainties that could cause our actual results to differ materially from those indicated by such forward-looking statements. These risks and uncertainties include those inherent in pharmaceutical research, such as adverse results in our drug discovery and clinical development processes, decisions made by the FDA and other regulatory authorities with respect to the development and commercialization of our products, and our ability to obtain, maintain and enforce proprietary rights for our products; our dependence on collaborative partners; our ability to obtain any necessary financing to conduct our planned activities, and other risk factors set forth in the filings that we make from time to time with the SEC. We disclaim any intention or obligation to update any forward-looking statements contained on this website, whether as a result of new information, future events or otherwise.

This Blog is official and sanctioned by Agenus | See Terms of Use | See Privacy Policy

Get Agenus Blog Post Alerts